Radioligand Therapy Set to Transform Oncology Care
Radioligand therapy (RLT) is projected to expand the pool of patients eligible for RLT by a factor of 10-15 by 2035 — and, with hundreds of clinical trials already underway and supported by a unique industrial ecosystem, is poised to be a major turning …